Theory Paper IIDrNB Cardiology – Theory Notes
APPLICATION OF MRI IN CARDIOMYOPATHIES
IDEFINITION AND CLINICAL ROLE
- Definition: Cardiovascular Magnetic Resonance (CMR) is the non-invasive reference standard for the precise quantification of biventricular volumes, ejection fraction, and myocardial mass, uniquely providing in vivo tissue characterization (edema, infiltration, and fibrosis) without ionizing radiation.
- Clinical Goal: To differentiate ischemic from non-ischemic cardiomyopathies, establish the specific etiology of non-ischemic phenotypes, and risk-stratify patients for Sudden Cardiac Death (SCD) and Implantable Cardioverter-Defibrillator (ICD) placement.
IICORE CMR SEQUENCES (THE TISSUE TOOLKIT)
- Cine Imaging (Steady-State Free Precession [SSFP]): The gold standard for assessing regional and global wall motion, exact biventricular ejection fraction (EF), and myocardial wall thickness.
- T2-Weighted Imaging and Parametric T2 Mapping: Detects increased myocardial free water content to identify acute myocardial edema (active inflammation, acute myocarditis, or acute ischemic injury).
- Parametric Native T1 Mapping and Extracellular Volume (ECV): Quantifies the interstitial space between myocytes. Elevated Native T1 and ECV detect diffuse interstitial fibrosis (e.g., early diabetic cardiomyopathy) or massive extracellular infiltration (the hallmark of Cardiac Amyloidosis), whereas low Native T1 identifies intracellular glycosphingolipid accumulation (Fabry disease) or myocardial iron overload.
- Late Gadolinium Enhancement (LGE): Gadolinium-based contrast agents are extracellular tracers that wash out of normal myocardium but pool in regions of expanded extracellular space or ruptured myocyte membranes, identifying focal replacement fibrosis and myocardial scar.
IIILGE PATTERNS: THE DIAGNOSTIC ROSETTA STONE
- Ischemic vs. Non-Ischemic Fundamental Rule:
- Ischemic Cardiomyopathy: LGE invariably involves the subendocardium and extends toward the epicardium (subendocardial to transmural) following the wavefront of necrosis within a specific epicardial coronary artery territory.
- Non-Ischemic Cardiomyopathy: LGE typically spares the subendocardium, localizing to the mid-wall or subepicardium in patterns that do not respect epicardial coronary distributions.
| Cardiomyopathy Phenotype | Classic LGE Distribution Pattern | Key Associated CMR / Parametric Hallmark |
|---|---|---|
| Ischemic Cardiomyopathy | Subendocardial to transmural within a coronary artery territory | Transmurality >50% predicts non-viable myocardium |
| Dilated Cardiomyopathy (DCM) | Linear mid-wall striae in the basal-to-mid interventricular septum | Strong independent predictor of VT and SCD regardless of LVEF |
| Hypertrophic Cardiomyopathy (HCM) | Patchy mid-wall LGE at the RV septal insertion points and most hypertrophied segments | LGE >=15% of LV mass is a major SCD risk factor (Class IIa for ICD) |
| Cardiac Amyloidosis | Global, circumferential subendocardial or transmural LGE (including atria/RV) | Abnormal inversion-time (TI) nulling kinetics (myocardium nulls before or with blood pool) + massively expanded ECV |
| Acute Myocarditis | Patchy subepicardial or mid-wall LGE, classically in the basal-to-mid inferolateral wall | Positive T2 edema + T1/LGE criteria (2018 Revised Lake Louise Criteria) |
| Cardiac Sarcoidosis | Multifocal, patchy basal septal, subepicardial, or transmural LGE extending into the RV | Basal septal thinning and “hook sign”; paired with 18F-FDG PET for active inflammation |
| ARVC / ACM | RV free-wall and LV subepicardial (“ring-like”) LGE with regional akinesia/dyskinesia/aneurysm | Quantifies Task Force RV End-Diastolic Volume Index and RVEF cut-offs |
IVPROGNOSTIC RISK STRATIFICATION AND ICD GUIDELINES (ESC 2023 / AHA-ACC 2024)
- Hypertrophic Cardiomyopathy (HCM): Extensive replacement fibrosis (LGE comprising 15 percent or more of total LV mass) or an LV apical aneurysm on CMR is a major independent risk factor for SCD and supports Class IIa primary-prevention ICD implantation, even when LVEF is preserved.
- Dilated and Non-Dilated Left Ventricular Cardiomyopathy (DCM / NDLVC): Presence of mid-wall septal LGE or subepicardial ring-like LGE (characteristic of high-risk DSP, FLNC, LMNA, and PLN genotypes) strongly predicts malignant ventricular arrhythmias and refines primary-prevention ICD selection beyond an isolated LVEF <=35 percent threshold.
- Cardiac Sarcoidosis: Presence of significant myocardial LGE on CMR is an independent Class IIa indication for primary-prevention ICD implantation even when LVEF is greater than 35 percent.
Key references
- Arbelo E, Protonotarios A, Gimeno JR, et al.: 2023 ESC Guidelines for the management of cardiomyopathies, European Heart Journal, 2023.
- Ommen SR, Ho CY, Asif IM, et al.: 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy, Circulation / Journal of the American College of Cardiology, 2024.
- Libby P, Bonow RO, Mann DL, Tomaselli GF, Bhatt DL, Solomon SD: Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 12th Ed., Elsevier, 2022.
meritmedscript.comDr. Sidhartha Mullapudi
